Drreddys Laboratories reported INR40.09B in Gross Profit on Sales for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Ani Pharmaceuticals ANIP:US USD 57.91M 6.98M
Aurora Cannabis Inc ACB:CN CAD -22470000 354K
Bayer BAYN:GR EUR 7.23B 198M
Canopy Growth Corp WEED:CN CAD -2441000 6.26M
Catalent CTLT:US USD 387M 129M
Cipla CIPLA:IN INR 38.06B 1.37B
Corcept Therapeutics CORT:US USD 101.58M 1.19M
Drreddys Laboratories RDY:US INR 40.09B 2.85B
Endo International Ordinary Shares ENDP:US USD 364.83M 28.49M
GlaxoSmithKline GSK:LN GBP 5.2B 244M
Hikma Pharmaceutical HIK:LN USD 642M 19M
Horizon Pharma HZNP:US USD 701.24M 10.01M
Lonza Group LONN:SW CHF 1.24B 46M
Novartis NOVN:VX USD 9.16B 21M
Pacira Pharmaceuticals PCRX:US USD 110.04M 6.75M
Phibro Animal Health PAHC:US USD 77.38M 8.74M
Prestige Brands PBH:US USD 150.4M 10.61M
Richter Gedeon RICHT:HB HUF 130.67B 20.64B
Sun Pharmaceuticals SUNP:IN INR 84.37B 1.93B
Supernus Pharmaceuticals SUPN:US USD 144.37M 7.1M
Teva Pharmaceutical TEVA:IT USD 2.1B 390M